Cannara Biotech Set for Toronto Stock Exchange Uplisting Amidst Growth
Cannara Biotech Inc. is poised for a significant move. The company has received conditional approval to list its common shares on the Toronto Stock Exchange (TSX). This transition marks an important step. It moves Cannara from the TSX Venture Exchange (TSXV). This uplisting aims to boost investor visibility. It also seeks to provide greater liquidity…

